Form 485BXT ETF Opportunities Trust
As filed with the Securities and Exchange Commission on June 8, 2026 | ||||||||
Securities Act Registration No. 333-234544 | ||||||||
Investment Company Act Registration No. 811-23439 | ||||||||
UNITED STATES | ||||||||
SECURITIES AND EXCHANGE COMMISSION | ||||||||
Washington, D.C. 20549 | ||||||||
FORM N-1A | ||||||||
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 | ||||||||
Pre-Effective Amendment No. ___ | [ ] | |||||||
Post-Effective Amendment No. 834 | [X] | |||||||
and/or | ||||||||
REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 | ||||||||
Amendment No. 836 | [X] | |||||||
ETF OPPORTUNITIES TRUST | ||||||||
(Exact Name of Registrant as Specified in Charter) | ||||||||
Karen Shupe Commonwealth Fund Services, Inc. 8730 Stony Point Parkway, Suite 205 Richmond, VA 23235 (804) 267-7400 | ||||||||
(Address and Telephone Number of Principal Executive Offices) | ||||||||
The Corporation Trust Co. | ||||||||
Corporation Trust Center, 1209 Orange St., Wilmington, DE 19801 | ||||||||
(Name and Address of Agent for Service) | ||||||||
With Copy to: | ||||||||
John H. Lively | ||||||||
Practus, LLP | ||||||||
11300 Tomahawk Creek Parkway, Suite 310 | ||||||||
Leawood, KS 66211 | ||||||||
It is proposed that this filing will become effective:
☐ | immediately upon filing pursuant to paragraph (b) | |||||||
X | on July 9, 2026 pursuant to paragraph (b) | |||||||
☐ | 60 days after filing pursuant to paragraph (a)(1) | |||||||
☐ | on (date) pursuant to paragraph (a)(1) | |||||||
☐ | 75 days after filing pursuant to paragraph (a)(2) | |||||||
☐ | on (date) pursuant to paragraph (a)(2) of Rule 485. | |||||||
If appropriate, check the following box:
X | This post-effective amendment designates a new effective date for a previously filed post-effective amendment. | |||||||
This filing relates solely to the following funds listed below, each a series of ETF Opportunities Trust (the "Funds"):
T-REX 2X LONG ANTHROPIC DAILY TARGET ETF | ||
This Post-Effective Amendment to the Registration Statement on Form N-1A is filed pursuant to Rule 485(b)(1)(iii) for the sole purpose of designating July 9, 2026 as the new effective date for Post-Effective Amendment No. 699 to the Registration Statement filed on March 26, 2026 for the following funds:
T-REX 2X LONG ANTHROPIC DAILY TARGET ETF | ||
This Post-Effective Amendment incorporates by reference the Prospectus and Statement of Additional Information contained in Post-Effective Amendment No. 699 to the Registration Statement.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended (the “Securities Act”), and the Investment Company Act of 1940, as amended, the Registrant certifies that it meets all of the requirements for effectiveness of this registration statement under Rule 485(b) of the Securities Act and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Richmond, Commonwealth of Virginia on the 8th day of June, 2026.
ETF OPPORTUNITIES TRUST
By: /s/ Karen M. Shupe
Karen M. Shupe
Treasurer and Principal Executive Officer
Karen M. Shupe
Treasurer and Principal Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this Amendment to the Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.
Signature | Title | Date | ||||||
*Mary Lou H. Ivey | Trustee | June 8, 2026 | ||||||
*Theo H. Pitt, Jr. | Trustee | June 8, 2026 | ||||||
*Dr. David J. Urban | Trustee | June 8, 2026 | ||||||
/s/ Karen M. Shupe | Treasurer and Principal Executive Officer | June 8, 2026 | ||||||
Karen M. Shupe | ||||||||
/s/ Ann T. MacDonald | Assistant Treasurer and Principal Financial Officer | June 8, 2026 | ||||||
Ann T. MacDonald | ||||||||
*By: /s/ Karen M. Shupe | ||||||||
Karen M. Shupe | ||||||||
*Attorney-in-fact pursuant to Powers of Attorney
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease
- The 6 Best Places to Get a Massage in Vancouver in 2026
- CZR Exchange Hosts Exclusive VIP Trading Community Experience During Monaco Grand Prix 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share